Literature DB >> 12144517

The systemic reaction during inflammation: the acute-phase proteins.

Fabrizio Ceciliani1, Alessia Giordano, Valentina Spagnolo.   

Abstract

The acute-phase response consists in a large number of behavioural, physiologic, biochemical, and nutritional changes involving many organ systems distant from the site, or sites, of inflammation. One of the most investigated, but still not well understood, characteristic of the acute phase is the up-regulation, or down- regulation, of many plasma proteins, known as the acute-phase proteins. The changes in the concentrations of these positive acute-phase proteins and negative acute-phase proteins are due to changes in their liver production. Their increase may vary from 25 percent to 1000 fold, as in the case of C-reactive protein and serum amyloid A. This review summarises the recent advances that have been acquired on the acute-phase proteins, in particular their function in pathologies such as infections or inflammatory lesions.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12144517     DOI: 10.2174/0929866023408779

Source DB:  PubMed          Journal:  Protein Pept Lett        ISSN: 0929-8665            Impact factor:   1.890


  53 in total

Review 1.  Protein biomarkers of ovarian cancer: the forest and the trees.

Authors:  Brian M Nolen; Anna E Lokshin
Journal:  Future Oncol       Date:  2012-01       Impact factor: 3.404

2.  Impact of body composition on clinical outcomes in metastatic renal cell cancer.

Authors:  Patricia A Tang; Daniel Y C Heng; Toni K Choueiri
Journal:  Oncologist       Date:  2011-10-21

3.  Acute phase proteins increase with sarcoptic mange status and severity in Iberian ibex (Capra pyrenaica, Schinz 1838).

Authors:  Arián Ráez-Bravo; José Enrique Granados; José Joaquín Cerón; Francisco Javier Cano-Manuel; Paulino Fandos; Jesús María Pérez; José Espinosa; Ramón Casimiro Soriguer; Jorge Ramón López-Olvera
Journal:  Parasitol Res       Date:  2015-07-31       Impact factor: 2.289

Review 4.  Factoring in Factor VIII With Acute Ischemic Stroke.

Authors:  James E Siegler; Alyana Samai; Karen C Albright; Amelia K Boehme; Sheryl Martin-Schild
Journal:  Clin Appl Thromb Hemost       Date:  2015-02-10       Impact factor: 2.389

5.  Identification of haptoglobin and apolipoprotein A-I as biomarkers for high altitude pulmonary edema.

Authors:  Yasmin Ahmad; Dhananjay Shukla; Iti Garg; Narendra K Sharma; Saurabh Saxena; V K Malhotra; Kalpana Bhargava
Journal:  Funct Integr Genomics       Date:  2011-07-14       Impact factor: 3.410

Review 6.  Undernutrition, the acute phase response to infection, and its effects on micronutrient status indicators.

Authors:  Kara A Bresnahan; Sherry A Tanumihardjo
Journal:  Adv Nutr       Date:  2014-11-14       Impact factor: 8.701

7.  Sequential adaptive changes in a c-Myc-driven model of hepatocellular carcinoma.

Authors:  James M Dolezal; Huabo Wang; Sucheta Kulkarni; Laura Jackson; Jie Lu; Sarangarajan Ranganathan; Eric S Goetzman; Sivakama S Bharathi; Kevin Beezhold; Craig A Byersdorfer; Edward V Prochownik
Journal:  J Biol Chem       Date:  2017-04-21       Impact factor: 5.157

8.  Associations of interleukin-6, C-reactive protein and serum amyloid A with mortality in haemodialysis patients.

Authors:  James B Wetmore; David H Lovett; Adriana M Hung; Galen Cook-Wiens; Jonathan D Mahnken; Saunak Sen; Kirsten L Johansen
Journal:  Nephrology (Carlton)       Date:  2008-09-25       Impact factor: 2.506

9.  Steroid hormones content and proteomic analysis of canine follicular fluid during the preovulatory period.

Authors:  Somayyeh Fahiminiya; Karine Reynaud; Valérie Labas; Séverine Batard; Sylvie Chastant-Maillard; Nadine Gérard
Journal:  Reprod Biol Endocrinol       Date:  2010-11-01       Impact factor: 5.211

10.  Association between serum levels of C-reactive protein and response to treatment of chemotherapy-induced anemia in patients with solid tumors: a multicenter, prospective, observational study.

Authors:  Gaspar Esquerdo Galiana; Jose Manuel Cervera; Enrique Barrajón; Asunción Juárez; Cristina Llorca; Nieves Díaz; Antonio López; Rafael Peiró
Journal:  Med Oncol       Date:  2013-02-01       Impact factor: 3.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.